Standing Stone’s CoagClinic™ Improves Patient Safety and Reduces Costs for Anticoagulation Therapy Management: Disease Management Software Helps to Reduce Adverse Events by 89%

WESTPORT, CT -- (Business Wire) --

December 3, 2007
By Cheryl Lechok

Standing Stone, Inc., a leader in disease state management solutions, announces that its CoagClinic™ software application can help hospitals, clinics and other healthcare facilities significantly improve patient safety in anticoagulation management. The software will also help these institutions meet stringent new Joint Commission 3E requirements for inpatient and outpatient anticoagulation therapy management, effective January 1, 2008.

An impact study by Dr. Mark Wurster, Clinical Assistant Professor of Internal Medicine at Ohio State University, concluded that anticoagulation therapy management systems which combine Point of Service (POS) testing with Computerized Decision Support (CDS), such as CoagClinic™, benefited both patients and care facilities as follows:

Reduced adverse events by 89% due to improved patient follow up and care

Increased International Normalized Ratio (INR) compliance to 62% vs. 38% compliance with traditional monitoring

Reduced total costs of therapy-related complications from $336,000 with traditional monitoring to $260 with POS/CDS systems

CoagClinic™ offers a web-based, customizable approach to the management and documentation of anticoagulation therapy. Key benefits include tracking use of approved protocols and potential for drug interactions, patient-specific support for warfarin and low molecular weight heparin dosing and documenting patient and caregiver education for follow up monitoring, compliance tracking, nutritional counseling and drug-drug interactions (DDI’s).

"Our company's mission is to provide tools that help improve patient outcomes while assisting healthcare professionals with daily efficiency," said Albert J. Bartosic, President of Standing Stone. He continued, "Our CoagClinic™ application has already helped over 400 hospitals and physician’s offices to improve the quality of care delivered around anticoagulation therapy. We are pleased that the Joint Commission is implementing their new 3E requirements to further promote patient safety within the hospital setting."

About Standing Stone, Inc.

Standing Stone (www.standingstoneinc.com), founded in 1998, is a disease state management company dedicated to enhancing the quality of care provided to patients who require long-term therapy for chronic disease management. The firm’s sophisticated web-based software applications are designed for use in clinical settings such as hospital systems, dedicated clinics or physician’s offices and can be securely accessed via the Internet.

Press Contact:
Cheryl Lechok
203.227.8710 X217
clechok@standingstoneinc.com

 

49 Richmondville Avenue, Westport, CT 06880   Tel: (800) 648-9877   E-mail: info@standingstoneinc.com